中汽協:首季汽車製造業累計利潤按年增長8.4倍
中國汽車工業協會公布,首季汽車製造業累計實現利潤1,320.8億元(下同),按年增長8.4倍,佔規模以上工業企業實現利潤總額的7.2%。
中汽協指,今年首季內地汽車製造業完成營業收入按年保持快速增長,達21,163億元人民幣,按年增長71.5%,增速高於同期規模以上工業企業32.8個百分點,佔規模以上工業企業營業收入總額7.7%。
另外,4月上中旬,11家重點企業汽車生產完成107.5萬輛,按年下降3.1%。其中,乘用車生產完成85.7萬輛,按年下降1.1%;商用車生產完成21.8萬輛,按年下降10.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.